Sun Pharma Rallies On BofA-ML Upgrade

Subscribe to GoodReturns
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

    Shares in Sun Pharma gained more than 2 percent to Rs 909, after BofA-ML upgraded the stock to "buy" from "neutral", raising its target price to Rs 1,070.

    Sun Pharma Rallies On BofA-ML Upgrade
    Sun Pharmaceutical Industries: Quotes, News
    BSE 531.15BSE Quote5.65 (1.06%)
    NSE 532.85NSE Quote7.4 (1.39%)
    Shares in Sun Pharma have seen some buying support in the last few weeks after the rupee depreciated against the Dollar.
     

    The stock had tumbled to a 52-week low of Rs 752, but, has recovered since. The drop was largely as a result of a poor set of quarterly numbers from the company.

    Sun Pharma has over the last quarter seen its performance deteriorate largely on account of the consolidated figures after merging with Ranbaxy.

    GoodReturns.in

    Read more about: sun pharma ranbaxy
    Story first published: Wednesday, August 19, 2015, 10:45 [IST]
    Company Search
    Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

    Find IFSC

    We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more